Elucidation of the clinical significance of autotaxin and lysophosphatidic acid in liver diseases.

阐明自分泌运动因子和溶血磷脂酸在肝脏疾病中的临床意义。

基本信息

  • 批准号:
    17590618
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

The clinical significance of lysophosphatidic acid(LPA), a novel phospholipid mediator, and its synthetic enzyme, autotaxin(ATX) was investigated in liver damages. Serum ATX activity and plasma LPA level were determined to be elevated in human chronic liver diseases correlatively with fibrosis. Plasma LPA level was correlated with serum ATX activity, suggesting that serum ATX activity is one of the determinants of plasma LPA level. To investigate whether the enhancement of serum ATX activity and/or plasma LPA level might be generally found in liver damages, the study in animal models was performed. Serum ATX activity and plasma LPA level were enhanced in rats with chronic carbon tetrachloride(CCl_4) intoxication correlatively with fibrosis, where ATX mRNA expression was not altered in the liver of CCl_4-treated rats, indicating that enhancement of serum ATX activity may not be due to increased ATX production at the transcriptional level in the liver. Serum ATX activity and plasma LPA level were also increased in rats with acute liver injury due to dimethylnitrosamine intoxication or 70% hepatectomized rats. In rats with dimethylnitrosamine intoxication, serum ATX activity was correlated with serum ALT level, and in 70% hepatectomized rats, serum ATX activity was enhanced as early as 3 hours after the operation and sustained at the same level up to 24 hours after hepatectomy. These results suggest that serum ATX activity and plasma LPA level may be increased generally in liver damages in relation to the severity. The mechanism of enhancement of serum ATX activity in liver damages may involve the reduced clearance of ATX in damaged liver. Whether the increases of serum ATX activity and plasma LPA level may be simply the result of liver damages or the cause of liver damages should be further clarified.
探讨新型磷脂介体溶血磷脂酸(LPA)及其合成酶自体趋化蛋白(ATX)在肝损伤中的临床意义。慢性肝病患者血清ATX活性和血浆LPA水平明显升高,与肝纤维化程度密切相关。血浆LPA水平与血清ATX活性呈正相关,提示ATX活性是血浆LPA水平的决定因素之一。为了探讨肝损伤是否普遍存在血清ATX活性和/或血浆LPA水平的升高,本研究在动物模型上进行了研究。慢性四氯化碳(CCl_4)中毒大鼠血清ATX活性和血浆LPA水平升高与肝纤维化程度相关,而肝组织ATX mRNA表达无明显变化,提示血清ATX活性升高可能不是由于肝脏转录水平ATX生成增加所致。二甲基亚硝胺急性肝损伤大鼠和70%肝切除大鼠的血清ATX活性和血浆LPA水平也明显升高。二甲基亚硝胺中毒大鼠血清ATX活性与血清ALT水平呈正相关,70%肝切除大鼠血清ATX活性在术后3小时即开始升高,并持续至术后24小时。提示在肝损害中,血清ATX活性和血浆LPA水平普遍升高,且与病情严重程度相关。肝损伤时血清ATX活性升高的机制可能与ATX在受损肝脏的清除减少有关。血清ATX活性和血浆LPA水平升高可能是单纯肝损害的结果,还是肝损害的原因有待进一步阐明。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IKEDA Hitoshi其他文献

IKEDA Hitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IKEDA Hitoshi', 18)}}的其他基金

A novel treatment for liver injury by modulation oflipid mediator effects
通过调节脂质介质效应治疗肝损伤的新方法
  • 批准号:
    22590716
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of a role of sphingosine 1-phosphate on liver damage
阐明 1-磷酸鞘氨醇对肝损伤的作用
  • 批准号:
    19590750
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of Hepatoblastoma Carcinogenesis in Low Birth Weight Infants
低出生体重儿肝母细胞瘤癌变机制
  • 批准号:
    15591892
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of the inhibitory effect of sphingosine 1-phosphate on hepatocyte proliferation and the significance in liver regeneration
阐明1-磷酸鞘氨醇抑制肝细胞增殖的机制及其在肝再生中的意义
  • 批准号:
    14570451
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
-General Study of the Chinese Agriculture and Rural Economy after joining World Trade Organization-
-加入世界贸易组织后中国农业农村经济概况-
  • 批准号:
    14402031
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
PORTAL HYPERTENSION-ELUCIDATION OF THE MECHANISM IN THE LIGHT OF FUNCTIONAL ABNORMALITIES OF HEPATIC STELLATE CELLS AND DEVELOPMENT OF THERAPEUTIC STRATEGY
门静脉高压——肝星状细胞功能异常的机制阐明及治疗策略的制定
  • 批准号:
    12670461
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathogenetic roles of human endogenous retroviruses in autoimmune diseases
人内源性逆转录病毒在自身免疫性疾病中的致病作用
  • 批准号:
    12670193
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ELUCIDATION OF SIGNIFICANCE OF c-met EXPRESSION IN ACTIVATED HEPATIC STELLATE GELLS AND ITS APPLICATION OF THERAPEUTIC STRATEGY
活化肝星状凝胶中c-met表达意义的阐明及其治疗策略的应用
  • 批准号:
    09670517
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mapping of the gene for Holmes' ataxia by searching of triplet repeats
通过搜索三联体重复序列绘制福尔摩斯共济失调基因图谱
  • 批准号:
    09470057
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Platelet Epidermal Growth Factor and Liver Regeneration
血小板表皮生长因子与肝脏再生
  • 批准号:
    62570313
  • 财政年份:
    1987
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Lysophosphatidic Acid and Cardiovascular Disease Risk
溶血磷脂酸与心血管疾病风险
  • 批准号:
    10614416
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
Lysophosphatidic Acid and Cardiovascular Disease Risk
溶血磷脂酸与心血管疾病风险
  • 批准号:
    10386914
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
Lysophosphatidic Acid and Cardiovascular Disease Risk
溶血磷脂酸与心血管疾病风险
  • 批准号:
    10258072
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of the lysophosphatidic acid in the glutamatergic neurotransmission abnormality of schizophrenia
溶血磷脂酸在精神分裂症谷氨酸神经传递异常中的作用
  • 批准号:
    20K07936
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Lysophosphatidic Acid Regulation of CD8 T cell activation and function
溶血磷脂酸对 CD8 T 细胞活化和功能的调节
  • 批准号:
    10116268
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Lysophosphatidic acid (LPA) is a novel FGF23 regulator in acute kidney injury.
溶血磷脂酸 (LPA) 是急性肾损伤中的一种新型 FGF23 调节剂。
  • 批准号:
    10542347
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Lysophosphatidic acid (LPA) is a novel FGF23 regulator in acute kidney injury.
溶血磷脂酸 (LPA) 是急性肾损伤中的一种新型 FGF23 调节剂。
  • 批准号:
    10320973
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Alcohol mediated myocardial lysophosphatidic acid signaling
酒精介导的心肌溶血磷脂酸信号传导
  • 批准号:
    9896130
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Lysophosphatidic Acid Regulation of CD8 T cell activation and function
溶血磷脂酸对 CD8 T 细胞活化和功能的调节
  • 批准号:
    10348723
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of lysophosphatidic acid signalling in mitochondrial function of heart muscle cells
溶血磷脂酸信号在心肌细胞线粒体功能中的作用
  • 批准号:
    550531-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了